Use of NOACS in high-risk patients with atrial fibrillation in Saudi Arabia: Perspectives on improving patient care-Reference-Cited by-同舟云学术

Use of NOACS in high-risk patients with atrial fibrillation in Saudi Arabia: Perspectives on improving patient care

Author:

AlShoaibi N¹^ORCID,Al Harbi M²,Modaimegh H³,Al Qubbany A⁴⁵,Al Saif S⁶,Connolly DL⁷^ORCID,Kharabsheh S⁸,Fathy M⁹,Hegazy Y¹⁰,Tarcha N⁹,Al Fagih A¹¹

Affiliation:

1. King Abdulaziz University Hospital, KSA

2. King Fahad Specialist Hospital, Dammam KSA

3. National Guard Hospital, KSA

4. King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Research Center, Jeddah, KSA

5. Ministry of National Guard, KSA

6. Saud Al Babtin Cardiac Center, KSA

7. Birmingham City Hospital & the Institute of Cardiovascular Sciences, University of Birmingham, UK

8. King Faisal Specialist Hospital, KSA

9. Pfizer Gulf LLC, UAE

10. Pfizer Saudi LTD, KSA

11. Prince Sultan Cardiac Centre, KSA

Funder

Pfizer Gulf FZ LLC

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

Reference120 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献